Psoriasis pathogenesis and the development of novel targeted immune therapies.
about
Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12Rβ1.Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.Psoriasis: A STAT3-Centric View.Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.The Genetic Basis of Psoriasis.MicroRNA-17-92 cluster promotes the proliferation and the chemokine production of keratinocytes: implication for the pathogenesis of psoriasis.Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment.Human αβ and γδ T Cells in Skin Immunity and Disease.The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis.A Task Force Against Local Inflammation and Cancer: Lymphocyte Trafficking to and Within the SkinResolvin E1 attenuates murine psoriatic dermatitisThe IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
P2860
Q47210888-E4927A3F-3C15-4B66-AB4F-5460079D4331Q47218445-1DC37FD5-E2D6-463A-865F-791C9F0FE8A9Q48278607-2ACED689-3035-4B8A-AB9A-8D50FFF561F3Q52664043-EE9CD27B-DFFC-46C9-8096-41C7F3D49DF3Q52765463-A183EC97-0574-4019-BDAD-24DDA6CDD3F5Q54979236-1A1C73A8-2D5D-401D-9EA1-A78653A6B7DBQ55115632-2BEEFB21-0873-450F-8191-1C8C9A9DCC9DQ55265385-2128086C-A3A6-46A5-97B4-D251EB054E6EQ55386458-ED357B2A-652C-4496-90A3-3FCCE03A5F07Q58566631-9AFDE812-6A49-4C42-95E6-3E5ABC9D70F8Q58796027-B542CDA9-1028-4F5B-8790-AD820F509011Q58803307-7C0DC2E9-6DCB-4E80-86ED-C64A3048ED3B
P2860
Psoriasis pathogenesis and the development of novel targeted immune therapies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Psoriasis pathogenesis and the development of novel targeted immune therapies.
@en
Psoriasis pathogenesis and the development of novel targeted immune therapies.
@nl
type
label
Psoriasis pathogenesis and the development of novel targeted immune therapies.
@en
Psoriasis pathogenesis and the development of novel targeted immune therapies.
@nl
prefLabel
Psoriasis pathogenesis and the development of novel targeted immune therapies.
@en
Psoriasis pathogenesis and the development of novel targeted immune therapies.
@nl
P2860
P1476
Psoriasis pathogenesis and the development of novel targeted immune therapies
@en
P2093
James G Krueger
Tom C Chan
P2860
P304
P356
10.1016/J.JACI.2017.07.004
P407
P577
2017-09-01T00:00:00Z